1 Beaten-Down Tech Stock You’ll Be Happy You Own in 2032

Nuvei (TSX:NVEI)(NASDAQ:NVEI) stock is a growth bargain that may be a wise investment 10 years from now.

| More on:
investment research

Image source: Getty Images

The past six months have been nothing short of painful, with the S&P 500 nosediving into a bear market, while the Nasdaq 100 fell well over 30% from peak to trough. Speculative tech stocks, like those within certain innovation ETFs, shed more than 70% of their value. Undoubtedly, there was a brutal crash within speculative growth plays, thanks in part to higher interest rates and a cooling in the speculative appetite.

Indeed, there was too much euphoria in 2021. These days, the euphoria has dissipated, with cryptocurrencies and other high-risk assets now off more than 50% from their peak levels. Though it’s hard to tell what comes next for markets, I think that investors should not overreact to the broadening out of the market pain or the economic damage that could be on the horizon.

Yes, a recession could hit in 2023. We’ve heard of rescinded job offers, hiring freezes, and layoffs. However, most of this activity has come from the tech sector. Indeed, 2022 has been akin to the tech bubble burst of 2000, perhaps with a bit of 1970s-style inflation thrown into the mix. If you stayed away from overvalued growth plays, you’re probably within distance of recovering over the next few months or years.

Though tech may still have more room to the downside, I’d argue that most investors who stay the course will be looking back at 2022 as nothing more than an opportunity to buy. In 10 years from now, many of the fallen tech darlings may prove smart market-beating bets. And in this piece, we’ll have a closer look at two growth plays that may be worth enduring a bit of short-term pain for a shot at sizeable longer-term gains.

Consider Nuvei (TSX:NVEI)(NASDAQ:NVEI).

Nuvei

Nuvei is a payments company that went public at a bad time, just months before the high-tech trade imploded on itself. These days, investors are souring on Nuvei and the broader fintech space. Payments are due to take a hit as the economy takes a few steps back. Still, Nuvei stock strikes me as a bargain at just north of six times sales. While the 61.8 times earnings multiple implies shares are still expensive, I’d argue that long-term investors are getting a decent risk/reward tradeoff at this juncture.

The company recently had its credit rating upgraded to BB- from B+ due to low leverage and a somewhat stable forward-looking outlook. Indeed, the balance sheet is on steady footing, even as the firm continues to invest in fintech innovations.

Nuvei is teaming up with the North American gaming industry, a deal that could lead to next-level growth. Though NVEI stock will fluctuate based on broader market moves, I’d argue the $6.3 billion could find itself worth a heck of a lot more 10 years from now.

How much more? Count me as unsurprised if Nuvei becomes a $15 billion company 10 years from now.

Bottom line

The growth trade won’t stay this sour forever. It could stay weak through 2023, as recession hits. However, those looking to invest for the next 10 years, rather than the next 10 months could have a lot to gain with NVEI shares at this crossroad.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nuvei Corporation.

More on Investing

Hand arranging wood block stacking as step stair with arrow up.
Dividend Stocks

1 Growth Stock With Legit Potential to Outperform the Market

Identifying the stocks that have outperformed the market (in the past) is relatively easy, but selecting the ones that will…

Read more »

healthcare pharma
Tech Stocks

Well Health Stock Is Up 7% After Earnings: What Investors Need to Know

Well Health is benefiting from strong demand as it digitizes healthcare and strives to improve patient outcomes.

Read more »

money cash dividends
Dividend Stocks

Passive Income: The Investment Needed to Yield $1,000 Per Annum

Do you want to generate a juicy passive-income stream? Here's a trio of stocks that can generate a yield of…

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Dividend Stocks

Here’s the Average TFSA Balance in 2024

The average TFSA balance has steadily risen over the last six years and surpassed $41,510 in 2023. Will the TFSA…

Read more »

Shopping card with boxes labelled REITs, ETFs, Bonds, Stocks
Dividend Stocks

Invest $10,000 in This Dividend Stock for $1,500.50 in Passive Income

If you have $10,000 to invest, then you likely want a core asset you can set and forget. Which is…

Read more »

Supermarket aisle with empty green shopping cart
Stocks for Beginners

Is Dollarama Stock a Buy?

Dollarama stock (TSX:DOL) has seen shares surge on the back of strong performance and a dividend boost, but it also…

Read more »

potted green plant grows up in arrow shape
Dividend Stocks

TFSA Set and Forget: 2 Dividend-Growth Superstars for the Long Run

I'd look to buy and forget CN Rail (TSX:CNR) and another Canadian dividend-growth sensation for decades at a time.

Read more »

Payday ringed on a calendar
Dividend Stocks

1 Passive-Income Stream and 1 Dividend Stock for $781.48 in Monthly Cash

Looking for passive income? Don't take out a loan with that high interest involved. Instead, consider this method for years…

Read more »